Predictive Factors of Rituximab Response in Rheumatoid Arthritis: Results From a French University Hospital

Highest clinical effectiveness of rituximab in autoantibody-positive patients with rheumatoid arthritis and in those for whom no more than one previous TNF antagonist has failed: pooled data from 10 European registries

(2011) K. Chatzidionysiou et al.   ANNALS OF THE RHEUMATIC DISEASES

B cell activation biomarkers as predictive factors for the response to rituximab in rheumatoid arthritis: A six-month, national, multicenter, open-label study

(2011) Jérémie Sellam et al.   ARTHRITIS AND RHEUMATISM

Blood memory B cells are disturbed and predict the response to rituximab in patients with rheumatoid arthritis

(2011) Jérémie Sellam et al.   ARTHRITIS AND RHEUMATISM

Effectiveness of Rituximab in Patients with Rheumatoid Arthritis: Observational Study from the British Society for Rheumatology Biologics Register

(2011) M. M. SOLIMAN et al.   JOURNAL OF RHEUMATOLOGY

Epstein–Barr virus in bone marrow of rheumatoid arthritis patients predicts response to rituximab treatment

(2010) Mattias Magnusson et al.   RHEUMATOLOGY

Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNF agents failed are associated with response to rituximab in rheumatoid arthritis

(2009) L. Quartuccio et al.   RHEUMATOLOGY

Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort

(2009) Jacques-Eric Gottenberg et al.   ARTHRITIS RESEARCH & THERAPY

Anti-CD20 therapy in patients with rheumatoid arthritis: Predictors of response and B cell subset regeneration after repeated treatment

(2008) Petra Roll et al.   ARTHRITIS AND RHEUMATISM